From Morgans,
Column 1 Column 2 Column 3 Column 4 Column 5 0 26/02/2020 ResApp Health RAP SPEC BUY No surprises given quarterly reporting. Focus will remain on commentary regarding first commercialisation deals (size/pricing/structure) in Europe and Australia followed by US post FDA children’s approval which we expect any day.
https://www.morgans.com.au/research-and-markets/reporting-calendar
GLTAH.
- Forums
- ASX - By Stock
- RAP
- 2020 The Year Of RAP
2020 The Year Of RAP, page-1072
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 284 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online